Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

Clinical trial NCT05456529 · COMPLETED

Trial details

NCT number: NCT05456529
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2022-09-01
Primary completion: 2024-05-17
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.